Stevanato Group SpA
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
46 / 240
Position in country
277 / 520
Return on Assets, %
7.8
-2.7
Net income margin, %
14.1
-6.7
EBITDA margin, %
27
5.6
Debt to Equity, %
35
15.1
Intangible assets and goodwill, %
3.9
4.7
Revenue CAGR 3Y, %
17.9
12.8
Total Equity change 1Y, %
17.2
-2.4
Revenue Y, % chg
13.9
0
P/E
50.2
32.1
P/BV
6.4
2
P/S
7.6
4.1
EV/S
7.9
3.6
EV/EBITDA
29.4
7.8
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
20.7
48.9
Forward P/E
42.3
25.5
Dividend Yield, %
0.1
0.8
Forward Dividend Yield, %
0.1
0.2
Expected dividend per share
0
0
Payout Ratio, %
9.8
10.1
Dividend Ex Date
2023-06-07
Competitors
Ranks
-
Stevanato Group SpA
00%
-
Lonza Group AG
00%
-
Samsung Biologics Co Ltd
00%
-
IQVIA Holdings Inc
00%
-
West Pharmaceutical Services Inc
00%
-
Agilent Technologies Inc
00%
-
Thermo Fisher Scientific Inc
00%
-
Danaher Corp
00%
-
Mettler-Toledo International Inc
00%
-
Sartorius Stedim Biotech SA
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Italy
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Sub-sector
Health Care
Capitalization (millions of $)
8872.5
Ticker
STVN.K
ISIN
IT0005452658
IPO date
2021-07-16
Availability on Russian exchanges
No
Reporting for
2024-03-07
Date fact. publication of reports
2023-12-31
Company Description
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: